• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: biologic and therapeutic implications.原位肝移植患者自体肝脏中的肝细胞癌:生物学及治疗意义
Hepatology. 2001 Sep;34(3):502-10. doi: 10.1053/jhep.2001.26633.
2
Hepatocellular carcinoma in hepatectomized patients: biologic and therapeutic implications.肝切除患者的肝细胞癌:生物学及治疗意义
Anticancer Res. 2005 Jul-Aug;25(4):3067-73.
3
Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.肝硬化合并小肝细胞癌患者的肝移植:术前影像学、切除标本组织学及预后组织学指标分析
Dig Surg. 2004;21(2):152-9; discussion 159-60. doi: 10.1159/000078741. Epub 2004 May 27.
4
ZIP4, a novel determinant of tumor invasion in hepatocellular carcinoma, contributes to tumor recurrence after liver transplantation.ZIP4是肝细胞癌肿瘤侵袭的一种新型决定因素,它会导致肝移植后肿瘤复发。
Int J Biol Sci. 2014 Feb 11;10(3):245-56. doi: 10.7150/ijbs.7401. eCollection 2014.
5
Hepatocellular carcinoma in liver transplant era: a clinicopathologic analysis.肝移植时代的肝细胞癌:临床病理分析
Transplant Proc. 2003 Dec;35(8):2986-90. doi: 10.1016/j.transproceed.2003.10.076.
6
Hepatocellular carcinomas with a high proliferation index and a low degree of apoptosis and necrosis are associated with a shortened survival.增殖指数高、凋亡和坏死程度低的肝细胞癌与生存期缩短有关。
Br J Cancer. 1996 May;73(9):1025-30. doi: 10.1038/bjc.1996.199.
7
Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study.肝硬化合并和不合并肝细胞癌患者肝移植后的生存率:一项对比研究。
Hepatology. 1997 Jun;25(6):1485-9. doi: 10.1002/hep.510250629.
8
Expression of matrix metalloproteinase-9 in predicting prognosis of hepatocellular carcinoma after liver transplantation.基质金属蛋白酶-9 的表达在预测肝移植后肝细胞癌预后中的作用。
Liver Transpl. 2010 May;16(5):621-30. doi: 10.1002/lt.22028.
9
Is liver resection justified in advanced hepatocellular carcinoma? Results of an observational study in 464 patients.晚期肝细胞癌行肝切除术是否合理?464例患者的观察性研究结果
J Gastrointest Surg. 2009 Jul;13(7):1313-20. doi: 10.1007/s11605-009-0903-x. Epub 2009 May 6.
10
Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma.颗粒蛋白-上皮素前体过表达促进肝细胞癌的生长和侵袭。
Clin Cancer Res. 2004 Nov 15;10(22):7629-36. doi: 10.1158/1078-0432.CCR-04-0960.

引用本文的文献

1
When to consider liver transplantation in hepatocellular carcinoma patients?肝细胞癌患者何时应考虑肝移植?
Hepat Oncol. 2017 Jan;4(1):15-24. doi: 10.2217/hep-2016-0010. Epub 2017 Jul 6.
2
Functional imaging of hepatocellular carcinoma using diffusion-weighted MRI and (18)F-FDG PET/CT in patients on waiting-list for liver transplantation.使用扩散加权磁共振成像(MRI)和(18)F-氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(PET/CT)对等待肝移植患者的肝细胞癌进行功能成像。
Cancer Imaging. 2016 Feb 16;16:4. doi: 10.1186/s40644-016-0062-8.
3
Radiologic complete response with sirolimus and sorafenib in a hepatocellular carcinoma patient who relapsed after orthotopic liver transplantation.西罗莫司和索拉非尼治疗原位肝移植后复发的肝细胞癌患者实现放射学完全缓解
J Gastrointest Cancer. 2011 Mar;42(1):50-3. doi: 10.1007/s12029-010-9196-2.
4
Liver transplantation for hepatocellular carcinoma: extension of indications based on molecular markers.肝细胞癌的肝移植:基于分子标志物的适应证扩展
J Hepatol. 2008 Oct;49(4):581-8. doi: 10.1016/j.jhep.2008.03.032. Epub 2008 May 20.
5
Positron emission tomography/computer tomography: challenge to conventional imaging modalities in evaluating primary and metastatic liver malignancies.正电子发射断层扫描/计算机断层扫描:在评估原发性和转移性肝脏恶性肿瘤方面对传统成像方式的挑战。
World J Gastroenterol. 2007 May 28;13(20):2775-83. doi: 10.3748/wjg.v13.i20.2775.
6
Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility.使用针吸活检对肝细胞癌肿瘤分级进行术前评估:对移植资格的影响。
Ann Surg. 2007 Mar;245(3):435-42. doi: 10.1097/01.sla.0000250420.73854.ad.
7
Two cases of pulmonary metastasis after living donor liver transplantation for hepatocellular carcinoma.两例肝细胞癌活体肝移植术后肺转移病例。
Ann Saudi Med. 2006 Sep-Oct;26(5):398-402. doi: 10.5144/0256-4947.2006.398.
8
Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma.肝移植用于治疗中分化或高分化肝细胞癌。
Ann Surg. 2004 Feb;239(2):150-9. doi: 10.1097/01.sla.0000109146.72827.76.

本文引用的文献

1
Genetic and molecular markers of urothelial premalignancy and malignancy.尿路上皮癌前病变和恶性病变的遗传及分子标志物。
Scand J Urol Nephrol Suppl. 2000(205):82-93. doi: 10.1080/003655900750169338.
2
Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system.肝细胞癌的肝移植:一种预后评分系统的提议
J Am Coll Surg. 2000 Oct;191(4):389-94. doi: 10.1016/s1072-7515(00)00688-8.
3
[Revisions in the WHO histological classification of urothelial bladder tumors and flat urothelial lesions].[世界卫生组织尿路上皮膀胱肿瘤及扁平尿路上皮病变组织学分类的修订]
Pathologe. 2000 May;21(3):211-7. doi: 10.1007/s002920050390.
4
Molecular epidemiology and carcinogenesis: endogenous and exogenous carcinogens.分子流行病学与致癌作用:内源性和外源性致癌物
Mutat Res. 2000 Apr;462(2-3):311-22. doi: 10.1016/s1383-5742(00)00015-6.
5
The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease.血管生成与癌症发生及恶性疾病进展过程中免疫反应之间的关系。
Eur J Cancer. 2000 Jan;36(2):151-69. doi: 10.1016/s0959-8049(99)00241-5.
6
Hepatocellular carcinoma.肝细胞癌
J Hepatol. 2000;32(1 Suppl):225-37. doi: 10.1016/s0168-8278(00)80428-6.
7
Vitamin E reduces chromosomal damage and inhibits hepatic tumor formation in a transgenic mouse model.在转基因小鼠模型中,维生素E可减少染色体损伤并抑制肝肿瘤形成。
Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2196-201. doi: 10.1073/pnas.040428797.
8
Balance of cell proliferation and apoptosis in breast carcinogenesis.乳腺癌发生过程中细胞增殖与凋亡的平衡
Breast Cancer Res Treat. 1999 Nov;58(2):163-9. doi: 10.1023/a:1006396103777.
9
Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?肝癌患者的病理TNM分期系统能否预测预后?
Cancer. 2000 Feb 1;88(3):538-43. doi: 10.1002/(sici)1097-0142(20000201)88:3<538::aid-cncr7>3.0.co;2-h.
10
beta-catenin signaling and cancer.β-连环蛋白信号传导与癌症
Bioessays. 1999 Dec;21(12):1021-30. doi: 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P.

原位肝移植患者自体肝脏中的肝细胞癌:生物学及治疗意义

Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: biologic and therapeutic implications.

作者信息

Kirimlioglu H, Dvorchick I, Ruppert K, Finkelstein S, Marsh J W, Iwatsuki S, Bonham A, Carr B, Nalesnik M, Michalopoulos G, Starzl T, Fung J, Demetris A

机构信息

Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA 15261, USA.

出版信息

Hepatology. 2001 Sep;34(3):502-10. doi: 10.1053/jhep.2001.26633.

DOI:10.1053/jhep.2001.26633
PMID:11526535
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2956439/
Abstract

The gross and histopathologic characteristics of 212 nonfibrolamellar hepatocellular carcinomas (HCCs) discovered in native livers removed at the time of liver transplantation were correlated with features of invasive growth and tumor-free survival. The results show that most HCCs begin as small well-differentiated tumors that have an increased proliferation rate and induce neovascularization, compared with the surrounding liver. But at this stage, they maintain a near-normal apoptosis/mitosis ratio and uncommonly show vascular invasion. As tumors enlarge, foci of dedifferentiation appear within the neoplastic nodules, which have a higher proliferation rate and show more pleomorphism than surrounding better-differentiated areas. Vascular invasion, which is the strongest predictor of disease recurrence, correlates significantly with tumor number and size, tumor giant cells and necrosis, the predominant and worst degree of differentiation, and the apoptosis/mitosis ratio. In the absence of macroscopic or large vessel invasion, largest tumor size (P <.006), apoptosis/mitosis ratio (P <.03), and number of tumors (P <.04) were independent predictors of tumor-free survival and none of 24 patients with tumors having an apoptosis/mitosis ratio greater than 7.2 had recurrence. A minority of HCCs (<15%) quickly develop aggressive features (moderate or poor differentiation, low apoptosis/mitosis ratio, and vascular invasion) while still small, similar to flat carcinomas of the bladder and colon. In conclusion, hepatic carcinogenesis in humans is a multistep and multifocal process. As in experimental animal studies, aggressive biologic behavior (vascular invasion and recurrence) correlates significantly with profound alterations in the apoptosis/mitosis ratio and with architectural and cytologic alterations that suggest a progressive accumulation of multiple genetic abnormalities.

摘要

对212例在肝移植时切除的原位肝脏中发现的非纤维板层型肝细胞癌(HCC)的大体和组织病理学特征,与侵袭性生长特征及无瘤生存期进行了相关性分析。结果显示,大多数HCC起初为小的高分化肿瘤,与周围肝脏相比,其增殖率增加并诱导新生血管形成。但在此阶段,它们保持接近正常的凋亡/有丝分裂比率,且很少出现血管侵犯。随着肿瘤增大,肿瘤结节内出现去分化灶,其增殖率更高,与周围高分化区域相比表现出更多的多形性。血管侵犯是疾病复发的最强预测指标,与肿瘤数量和大小、肿瘤巨细胞和坏死、主要及最差分化程度以及凋亡/有丝分裂比率显著相关。在无宏观或大血管侵犯的情况下,最大肿瘤大小(P <.006)、凋亡/有丝分裂比率(P <.03)和肿瘤数量(P <.04)是无瘤生存期的独立预测指标,24例凋亡/有丝分裂比率大于7.2的肿瘤患者均无复发。少数HCC(<15%)在仍较小时就迅速出现侵袭性特征(中度或低分化、低凋亡/有丝分裂比率和血管侵犯),类似于膀胱和结肠的扁平癌。总之,人类肝癌发生是一个多步骤、多灶性过程。如同在实验动物研究中一样,侵袭性生物学行为(血管侵犯和复发)与凋亡/有丝分裂比率的深刻改变以及提示多种基因异常逐渐积累的结构和细胞学改变显著相关。